Big win for brand-name pharma companies in PTAB final decision

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Big win for brand-name pharma companies in PTAB final decision

December 13 2014

In a PTAB decision that brand-name pharmaceutical companies will celebrate, generic drug company Amneal has failed in its attempt to have three patents owned by Galderma cancelled – the first final written decision to involve an Orange Book-listed patent

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Request Access or Login

Topics

News Patents Jurisdictions United States (National)
more from across site and SHARED ros bottom lb

More from across our site

Patents
FPA SG Team2.jpg
Lateral hires boost FPA’s Singapore office
Eight years after its launch, members of the Australian patent firm’s Singapore office explain its growth strategy over the past year
James Nurton, November 10 2026
Patents
DigitalIP.jpg
Kenya: From the farm to the laptop, protecting IP in a digital world
Lawyers at Bowmans Kenya discuss the digital blind spots posed by the transition from physical ledgers to cloud databases and digital co-development models
Dominic Indokhomi, November 10 2026
Patents
Penny Gilbert NEW.jpg
Penny Gilbert: from pouring the tea to founding a law firm
The Powell Gilbert co-founder discusses the confidence required to launch a firm, building an enduring patent litigation practice and why developing the next generation has changed her measure of success
Max Walters, November 10 2026
Patents
Raluca-w-cup-of-coffee.jpg
Law firm founder on AI, patent drafting and changing client expectations
Cabinet M Oproiu’s Raluca Vasilescu explains why AI is changing what clients expect from patent attorneys, where the technology is overhyped and what the next generation will need to do differently
November 09 2026
Patents
AIprice.jpg
Beyond the headlines: AI is changing IP pricing, but don’t expect a revolution yet
As clients demand more flexible fees and AI-driven efficiencies, IP firms are rethinking pricing without abandoning the value of their work
Sukanya Sarkar, November 09 2026
Patents
Eyes2.jpg
‘Eyes wide open’: Ropes spin-out HG Law applies Fish & Neave lessons to Lathrop deal
HG Law was formed largely by ex Fish & Neave lawyers who left after the latter's merger with Ropes & Gray; now those experiences are shaping its latest combination
Sanjana Mishra, November 09 2026
Trademarks
Preserve value.jpg
Before distress hits: protecting and maximising IP value
David Rodrigues and Evan Lazerowitz – attorneys at Robinson & Cole – offer practical guidance on the steps a business might consider to preserve and maximise IP value before entering financial distress or insolvency
Evan Lazerowitz, November 09 2026
Patents
Alicia.jpg
‘Not the heiress, but the successor’: a new vision for a family firm
Daniel Law CEO Alicia Daniel-Shores may have stepped into a family business, but she has spent two decades building her own vision around technology and litigation
Sanjana Mishra, November 06 2026
Patents
selling.jpg
Weekly take: Law firms can’t bluff their way to IP expertise
Law firms don't particularly like saying no to clients. Perhaps they should get better at it
November 06 2026
Patents
twfrance.jpg
Taylor Wessing’s France office minded to shun proposed merger
The office, which has a relatively new patent litigation team as well as a wider ‘soft’ IP offering, would remain independent if the rejection is rubberstamped
Max Walters, November 05 2026
Gift this article